Last Update

This profile was last updated on 10/31/2017 and contains contributions from the  ZoomInfo Community.

is this you? Claim your profile.

Wrong Jill Crandall?

Jill P. Crandall

Professor of Medicine

Albert Einstein College of Medicine

HQ Phone:  (718) 430-2000

Direct Phone: (718) ***-****direct phone

Email: c***@***.edu

Get Zoominfo Grow
Community Edition

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    the Plugin
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check Your Inbox to
    Sign Up for ZoomInfo Community Edition

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Albert Einstein College of Medicine

1300 Morris Park Avenue

The Bronx, New York, 10461

United States

Company Description

About Albert Einstein College of Medicine ?Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation. During the 2015-2016 academic year, Einstein is home to 731 M.D. students, 193 Ph....more

Find other employees at this company (4,940)

Web References(122 Total References)


Do Statins Raise Odds for Type 2 Diabetes? - Healthcare Pass

"In a group of people at high risk of type 2 diabetes, statins do seem to increase the risk of developing diabetes by about 30 percent," said the study's lead author, Dr. Jill Crandall.
She's a professor of medicine and director of the diabetes clinical trials unit at Albert Einstein College of Medicine in New York City. But, she added, that doesn't mean anyone should give up on statins. "The benefits of statins in terms of cardiovascular risk are so strong and so well established that our recommendation isn't that people should stop taking statins, but people should be monitored for the development of diabetes while on a statin," she explained. The research goal was to prevent the progression of type 2 diabetes in people with a high risk of the disease, Crandall said. However, Crandall said the researchers measured levels of insulin secretion and insulin resistance. Insulin is a hormone that helps the body usher the sugar from foods into the body's cells to be used as fuel. Crandall said insulin secretion goes down when people take statins. Less insulin would lead to higher blood sugar levels. She said there was no indication that statins affected insulin resistance. Though they weren't included in this study, people who already have type 2 diabetes should be closely monitored for increases in blood sugar when they start taking a statin, Crandall said. "The evidence so far is rather limited, but there have certainly been anecdotal reports of blood sugar being higher when someone starts statins," she said. She also suggested that blood sugar levels likely aren't as much of a concern for those without diabetes or risk factors for diabetes when starting a statin. Besides excess weight, those risks include older age, high blood pressure and a family history of diabetes. Crandall added that there are many people 50 and over with prediabetes who don't know it, so it could be an issue for them. SOURCES: Jill Crandall, M.D., professor, medicine, and director, diabetes clinical trials unit, Albert Einstein College of Medicine, New York City; Daniel D. Donovan Jr., M.D., professor, medicine, and director, clinical research, Icahn School of Medicine, Mount Sinai Diabetes, Obesity and Metabolism Institute, New York City; Oct. 23, 2017, BMJ Open Diabetes Research & Care


Statins linked to diabetes risk | Cosmos

In a paper published in the British Medical Journal, a team of scientists led by Jill Crandall of the Albert Einstein College of Medicine in New York, US, reports that in people at high risk of developing diabetes statin use heightened the chances of doing so by 30%.
To make their finding, Crandall and colleagues used data obtained during a long-running US study known as the Diabetes Prevention Program Outcomes Study (DPPOS). Crandall and her colleagues opted instead to look specifically at people already identified as being at significant risk of developing diabetes.


Do Statins Raise Odds for Type 2 Diabetes? | Miami Dade Surgical Group

"In a group of people at high risk of type 2 diabetes, statins do seem to increase the risk of developing diabetes by about 30 percent," said the study's lead author, Dr. Jill Crandall.
She's a professor of medicine and director of the diabetes clinical trials unit at Albert Einstein College of Medicine in New York City. But, she added, that doesn't mean anyone should give up on statins. "The benefits of statins in terms of cardiovascular risk are so strong and so well established that our recommendation isn't that people should stop taking statins, but people should be monitored for the development of diabetes while on a statin," she explained. The research goal was to prevent the progression of type 2 diabetes in people with a high risk of the disease, Crandall said. However, Crandall said the researchers measured levels of insulin secretion and insulin resistance. Insulin is a hormone that helps the body usher the sugar from foods into the body's cells to be used as fuel. Crandall said insulin secretion goes down when people take statins. Less insulin would lead to higher blood sugar levels. She said there was no indication that statins affected insulin resistance. Though they weren't included in this study, people who already have type 2 diabetes should be closely monitored for increases in blood sugar when they start taking a statin, Crandall said. "The evidence so far is rather limited, but there have certainly been anecdotal reports of blood sugar being higher when someone starts statins," she said. She also suggested that blood sugar levels likely aren't as much of a concern for those without diabetes or risk factors for diabetes when starting a statin. Besides excess weight, those risks include older age, high blood pressure and a family history of diabetes. Crandall added that there are many people 50 and over with prediabetes who don't know it, so it could be an issue for them. SOURCES: Jill Crandall, M.D., professor, medicine, and director, diabetes clinical trials unit, Albert Einstein College of Medicine, New York City; Daniel D. Donovan Jr., M.D., professor, medicine, and director, clinical research, Icahn School of Medicine, Mount Sinai Diabetes, Obesity and Metabolism Institute, New York City; Oct. 23, 2017, BMJ Open Diabetes Research & Care


New Research Shows Long Term Metformin Use Lowers B12 Levels - Inland Naturopathic Medical Center

Dr. Jill P. Crandall of the Albert Einstein College of Medicine in New York City analyzed the data of two large studies, the Diabetes Prevention Program and the Diabetes Prevention ProgramOutcomes Study, for the relationship of Metformin use and B12 levels.
B12 values were measured in one group taking Metformin and another group taking a placebo. Dr. Crandall did not draw that conclusion but did propose that patients undergoing long term Metformin therapy should have their B12 values measured.


Long-Term Metformin Use Linked with Vitamin B12 Deficiency

With commentary by Jill Crandall, MD, professor of clinical medicine, Albert Einstein College of Medicine, New York.
Long-term use of the popular diabetes drug metformin is linked with vitamin B12 deficiency and anemia, according to new research that solidifies some previous research. vitamin b12 "We have essentially confirmed what many smaller studies have suggested," says Jill Crandall, MD, professor of clinical medicine at the Albert Einstein College of Medicine, the Bronx, who led the new study. "There is a small but significant risk of developing Vitamin B12 deficiency when people take metformin." The finding, she adds, ''has implications for the consequences of B12 deficiency. These can include cognitive impairment, nerve problems (neuropathy) and anemia (low red blood cell count). B12 is crucial for the proper formation of red blood cells, for neurological functioning and for making DNA. The link between taking the popular diabetes drug and deficiencies in vitamin B12 has been discussed as long ago as 1969, according to Dr. Crandall. However, few studies have looked at long term use, as her new study has done, tracking people for up to 13 years. The narrowed gap seems counter-intuitive until Dr. Crandall explains what is happening. "As time goes on, the groups are a little contaminated," Dr. Crandall says, because some in the placebo group, as time went on, developed diabetes and had to begin taking metformin. Years of use was linked with an increased risk of B12 deficiency, Dr. Crandall found. Those taking metformin were more likely to have anemia, regardless of their B12 status. Those taking metformin with low B12 were more likely to have neuropathy. The study findings suggest that routine testing of Vitamin B12 should be considered in patients on metformin treatment, Dr. Crandall says. Experts think that metformin affects the way Vitamin B12 is absorbed by the body. "People should be aware of this possibility," Dr. Crandall says of the metformin and low B12 link. Currently, she says, there are no official recommendations for B12 testing of those on metformin. Symptoms of B12 deficiency may include numbness, tingling in the feet, and memory problems, Dr. Crandall says.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory